|
Walgreens, Jewel-Osco, Walmart and suburban Cook County are now scheduling COVID-19 vaccine appointments for eligible Chicago area residents.
|
RELATED ARTICLES | | |
|
 Shares of Humanigen Inc. were down 2.5% in trading on Monday after it announced a contract development and manufacturing deal with Emergent BioSolutions Inc. for its experimental COVID-19 treatment. Emergent's stock was down 1.7%. The investigational therapy, lenzilumab, is currently being tested in a Phase 3 trial in hospitalized COVID-19 patients. Humanigen said it plans to file for emergency use authorization in the first quarter of this year. Emergent has signed a number of deals to manufacture COVID-19 treatments and vaccines during the pandemic, including with AstraZeneca and Johnson & Johnson and with the Biomedical Advanced Research and Development Authority. Over the past 12 months, Humanigen's stock has soared 855.5%, shares of Emergent are up 88.4%, and the S&P 500 has gained 15.6%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
RELATED ARTICLES | | |
|
